BBIO icon

BridgeBio Pharma

179 hedge funds and large institutions have $1.1B invested in BridgeBio Pharma in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 55 increasing their positions, 71 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding:

1.23% less ownership

Funds ownership: 97.96%96.72% (-1.2%)

23% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 71

24% less capital invested

Capital invested by funds: $1.44B → $1.1B (-$342M)

Holders
179
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.08M
Puts
$761K
Net Calls
Net Calls Change

Top Buyers

1 +$8.12M
2 +$6.87M
3 +$6.67M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.47M
5
BlackRock
BlackRock
New York
+$3.83M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$237M
2
$203M
3
$80.7M
4
$74.4M
5
$67.4M
6
$46.2M
7
$39.5M
8
$28.3M
9
$21.9M
10
$20.6M
11
$16.9M
12
$15.7M
13
$14.2M
14
$12.9M
15
$10.6M
16
$10.4M
17
$10.3M
18
$9.78M
19
$9.16M
20
$8.05M
21
$7.85M
22
$7.32M
23
$7.17M
24
$7.12M
25
$6.96M